Slide 1: H1 2023 Results Presentation
• H1 2023 RESULTS PRESENTATION • September 5th, 2023
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary Key H1 2023 trends H1 2023 Sales up +28% YoY driven by Healthcare (including impact of 2022 acquisitions) and Safety divisions EBITDA Adjusted
Slide 3: GVS – H1 2023 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx GVS – H1 2023 Results At-a-Glance Continuous sales growth, profitability recovery and NFP reduction SALES EBITDA Adjusted and % NFP Adjusted and Leverage €m €m
Slide 4: Focus on Sales – H1 2023 vs. H1 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – H1 2023 vs. H1 2022 Consistent sales growth by quarter H1 2023 SALES VS. 2022 ACTUAL AND PRO-FORMA(1) – QUARTERLY EVOLUTION €m €m €m +5.0% +2.2
Slide 5: Focus on Sales – Organic vs. M&A
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – H1 2023 – Organic vs. M&A Strong impact of M&A synergies in Q2, with recovery of organic sales H1 2023 SALES VS. 2022 PRO-FORMA(1) – ORGANIC vs
Slide 6: Focus on Sales – Q2 2023 vs. Q1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – Q2 2023 vs. Q1 2023 Q2 sales growth supported by volume recovery SALES – Q1 2023 TO Q2 2023 BRIDGE €m • Q2 2023 sales growth vs. Q1 (+5.3%) sup
Slide 7: Focus on Sales – H1 2023 vs. H1 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – H1 2023 vs. H1 2022 1H 2023 performance supported by M&A and price increase SALES – H1 2022 TO H1 2023 BRIDGE €m • 1H 2023 volume decrease vs.
Slide 8: Focus on Sales – H1 2023 Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales - H1 2023 Performance by Division Healthcare and Safety leading the growth, Mobility still hit by de-stocking Healthcare & Life Sciences Health &
Slide 9: Focus on Profitability – EBITDA evolution by quarter
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Profitability – EBITDA evolution by quarter Q-on-Q profitability recovery continues EBITDA – Q3 2022 – Q2 2023 QUARTERLY EVOLUTION €m 24.5 22.1 22.6 17
Slide 10: Focus on Profitability – EBITDA Q2 2023 vs. Q1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Profitability – EBITDA Q2 2023 vs. Q1 2023 Q2 EBITDA growth driven by volumes and pricing EBITDA – Q1 2023 TO Q2 2023 BRIDGE €m • Q2 2023 EBITDA growth
Slide 11: Focus on Profitability – EBITDA H1 2023 vs. H1 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Profitability – EBITDA H1 2023 vs. H1 2022 Price increase and M&A fully offset the volume decrease EBITDA – H1 2022 TO H1 2023 BRIDGE €m • 1H 2023 volu
Slide 12: Focus on Debt – NFP Adjusted H1 2023 vs. Q1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Debt – NFP Adjusted H1 2023 vs. Q1 2023 NFP Adjusted improvement driven by tighter NWC control NET FINANCIAL POSITION ADJUSTED – Q1 2023 TO H1 2023 BRI
Slide 13: Appendix – Support Material
Appendix – Support Material
Slide 14: H1 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2023 Results – Financial Statements H1 2022 and H1 2023 P&L – Statutory Adjusted View of which H1 2022 of which H1 2023 €m H1 2022 % H1 2023 % non-recurring
Slide 15: H1 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2023 Results – Financial Statements Reclassified Balance Sheet - FY 2022 – H1 2023 FY 2022 H1 2023 €m Net intangible fixed assets 494.8 481.2 Net usage right
Slide 16: H1 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2023 Results – Financial Statements Cash Flow Statement - H1 2022 – H1 2023 €m H1 2022 H1 2023 Pre-tax result 42.5 10.0 Amortisation, depreciation and writed
Slide 17: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate